The table below shows the adverse reactions that happened in more than 20.0%
of participants in either group. There were other adverse reactions, but those
happened in fewer participants.
Most common adverse reactions
Relapsed/Refractory Treatment-Na√Øve
Adverse reaction (out of 32 participants) (out of 16 participants)
Headache 59.4% (19) 68.8% (11)
Bleeding under the skin 56.3% (18) 68.8% (11)
High blood pressure 53.1% (17) 31.3% (5)
Muscle pain 43.8% (14) 25.0% (4)
Diarrhea 40.6% (13) 37.5% (6)
Decreased amount of a type
of white blood cell called 28.1% (9) 12.5% (2)
neutrophils
Infection of the nose and throat 25.0% (8) 37.5% (6)
Weight increase 25.0% (8) 25.0% (4)
Decreased amount of a type
of white blood cell called CD4 21.9% (7) 12.5% (2)
lymphocytes
Tiny blood spots under the skin 21.9% (7) 25.0% (4)
Joint pain 18.8% (6) 37.5% (6)
Flu-like sickness 15.6% (5) 37.5% (6)
Low level of red blood cells 0.0% (0) 25.0% (4)
Swelling of the lower legs or
12.5% (4) 25.0% (4)
hands
Decreased amount of a type of
18.8% (6) 25.0% (4)
blood cell called platelets
Inflammation of the sinuses 15.6% (5) 25.0% (4)
14 | Clinical Study Results